{"id":625232,"title":"Annex 1 to the Good manufacturing practices guide – Manufacture of sterile drugs (GUI-0119): Overview - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T09:56:45.082000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/gmp-guidelines-annex-1-manufacture-sterile-drugs-0119.html","snippet":"Annex 1 to the Good manufacturing practices guide - Manufacture of sterile drugs (GUI-0119) - Summary Overview Principle, pharmaceutical quality system Premises, equipment, utilities and personnel Production and specific technologies Environmental and process monitoring Quality…","rawSnapshotUrl":"/api/snapshots/raw/625232","browseUrl":"https://replay.healtharchive.ca/job-6/20260227095645/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/gmp-guidelines-annex-1-manufacture-sterile-drugs-0119.html#ha_snapshot=625232","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}